Indaptus Therapeutics将执行1比28反向股票分割

2025-06-25 19:57

Indaptus Therapeutics (NASDAQ:INDP) has approved a 1-for-28 reverse stock split of its common stock, effective after trading closes on June 26, 2025.
The stock split is intended to increase the per share price and bid price of the company’s common stock to regain compliance with the continued listing requirements of Nasdaq.
The number of authorized shares of the company’s common stock will not change, while the number of outstanding shares will be reduced from approximately 16M to approximately 572 thousand.
INDP -30.5% premarket.

More on Indaptus Therapeutics